Profound Medical Corp. Reports Q3 2026 Results and Business Update

What Happened

• Profound Medical Corp. (PROF) filed a Form 8‑K on August 6, 2026 under Item 2.02 to announce its financial results for the quarter ended June 30, 2026 and to provide a business update.
• The company furnished a press release dated August 6, 2026 as Exhibit 99.1 containing the quarterly results and the business update. The Form 8‑K was signed by Chief Financial Officer Rashed Dewan.

Key Details

• Filing date: August 6, 2026 (Form 8‑K, Item 2.02 – Results of Operations and Financial Condition).
• Reporting period: Quarter ended June 30, 2026.
• Press release: Furnished as Exhibit 99.1 to the 8‑K (dated August 6, 2026).
• Signature: Form 8‑K signed by CFO Rashed Dewan.

Why It Matters

• This filing signals that Profound has released its quarterly earnings and related business information; investors should read the furnished press release (Exhibit 99.1) for revenue, profit/loss, cash flow, and any operational or strategic updates.
• Quarterly results can affect the stock price and inform decisions about buying, holding, or selling; the 8‑K ensures the company has publicly disclosed those results in compliance with SEC rules.